AUSL di Frosinone - Presidio Ospedaliero SS. Trinità
- Address
- lock Available on a paid plan
AUSL di Frosinone - Presidio Ospedaliero SS. Trinità
The AUSL di Frosinone - Presidio Ospedaliero SS. Trinità is a clinical research facility specializing in oncology research, with particular emphasis on breast cancer treatment optimization. The center focuses on advancing therapeutic strategies for post-menopausal women with hormone-responsive malignancies, contributing to the understanding of optimal treatment sequencing and integration.
- Adjuvant therapy protocols for early-stage breast cancer
- Endocrine-responsive tumor treatment strategies
- Optimization of chemotherapy and hormonal therapy timing
The center's research portfolio addresses critical questions in breast cancer management, particularly investigating the optimal integration of chemotherapy and aromatase inhibitors. Their work aims to define evidence-based approaches for combining systemic treatments in the adjuvant setting, focusing on disease recurrence prevention and improved outcomes for women with hormone receptor-positive breast cancer.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in AUSL di Frosinone - Presidio Ospedaliero SS. Trinità
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase III Evaluation of Concurrent Versus Sequential Chemotherapy and Aromatase Inhibitors (Exemestane, Letrozole, Anastrozole) in Endocrine-Responsive Early Breast Cancer | IRCCS Ospedale Policlinico San Martino | Phase III | Not Recruiting | Feb 2025 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Anastrozole | 1 | Unknown | 2025-02-03 | 2025-02-03 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.